200 related articles for article (PubMed ID: 11849319)
1. Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms.
Kakuta S; Tagawa Y; Shibata S; Nanno M; Iwakura Y
Immunology; 2002 Jan; 105(1):92-100. PubMed ID: 11849319
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread.
Zöller M; Strubel A; Hämmerling G; Andrighetto G; Raz A; Ben-Ze'ev A
Int J Cancer; 1988 Feb; 41(2):256-66. PubMed ID: 3123403
[TBL] [Abstract][Full Text] [Related]
6. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
[TBL] [Abstract][Full Text] [Related]
7. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.
Kitajima M; Abe T; Miyano-Kurosaki N; Taniguchi M; Nakayama T; Takaku H
Mol Ther; 2008 Feb; 16(2):261-8. PubMed ID: 18059370
[TBL] [Abstract][Full Text] [Related]
8. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
9. Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma.
Yim JH; Wu SJ; Lowney JK; Vander Velde TL; Doherty GM
J Interferon Cytokine Res; 1999 Jul; 19(7):723-9. PubMed ID: 10454342
[TBL] [Abstract][Full Text] [Related]
10. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
11. Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
Buhtoiarov IN; Sondel PM; Eickhoff JC; Rakhmilevich AL
Immunology; 2007 Mar; 120(3):412-23. PubMed ID: 17163960
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of IFN-lambda in murine tumor models.
Sato A; Ohtsuki M; Hata M; Kobayashi E; Murakami T
J Immunol; 2006 Jun; 176(12):7686-94. PubMed ID: 16751416
[TBL] [Abstract][Full Text] [Related]
13. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
Gold JE; Osband ME
Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
[TBL] [Abstract][Full Text] [Related]
14. Activation of IRF3 contributes to IFN-γ and ISG54 expression during the immune responses to B16F10 tumor growth.
Guinn Z; Brown DM; Petro TM
Int Immunopharmacol; 2017 Sep; 50():121-129. PubMed ID: 28651122
[TBL] [Abstract][Full Text] [Related]
15. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.
Kurosawa S; Harada M; Matsuzaki G; Shinomiya Y; Terao H; Kobayashi N; Nomoto K
Immunology; 1995 Jun; 85(2):338-46. PubMed ID: 7642226
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM
J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059
[TBL] [Abstract][Full Text] [Related]
18. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
19. IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.
Zöller M
Clin Exp Metastasis; 1988; 6(5):411-29. PubMed ID: 3132343
[TBL] [Abstract][Full Text] [Related]
20. Role of natural killer cells in intraocular melanoma metastasis.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N; Mizuno K
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):516-8. PubMed ID: 3957568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
